Mindestbestellung 115 CHF Kostenlose Lieferung ab 235 CHF Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 235 CHF Aktionen

Cathinon-Derivate

2-MMC 2-Methylmethcathinon

2-MMC 2-Methylmethcathinon. CAS-Nummer: 1246911-71-6. Summenformel: C11H15NO. Molekulargewicht: 177.24 g/mol. Chemische Parameter stehen in der Tabelle der Produkteigenschaften.

Chemischer Name
2-(methylamino)-1-(2-methylphenyl)propan-1-one
Weitere Namen
2-Methylmethcathinon, 2-MMC
CAS-Nummer
1246911-71-6
Summenformel
C11H15NO
Molekulargewicht
177.24 g/mol
Chemische Form
Erscheinungsbild
Herkunftsland
Zustand
Neu

10.00 CHF

Portion

10.00 CHF / 1 g 10.00 CHF

  • Externe Laborprüfung (≥98%) sowie vollständiges CAS-Eigenschaftsblatt auf der Produktkarte.
  • Diskretes, neutrales Paket (Packstation / Kurier) oder fertige Dead-Drop-Abholung in Ihrer Stadt.
  • Kauf ohne Pflichtregistrierung (BTC / XMR) · 24/7 Live-Chat (14:00–22:00 Schicht unserer Chemikerin).

Referenzinformationen

4,8 (31)

2-MMC 2-Methylmethcathinon gehört zur Kategorie „Cathinon-Derivate“. Chemischer Name (IUPAC): 2-(methylamino)-1-(2-methylphenyl)propan-1-one. Weitere Namen: 2-Methylmethcathinon, 2-MMC, 2MMC, 2 MMC. CAS-Nummer: 1246911-71-6. Summenformel: C11H15NO. Molekulargewicht: 177.24 g/mol.

Verfügbare Portionsgrößen auf dieser Karte bei RC Drogen Schweiz: 1 g, 5 g, 10 g, 25 g, 50 g, 100 g, 1000 g. Bestellungen werden per Kurier, Paketstation oder über fertige Dead-Drop-Dead Drops auf der Karte abgewickelt. Zahlung mit Bitcoin (BTC) und Monero (XMR). Cathinon-Derivate: 3-CMC Clofedron, 3-MMC 3-Methylmethcathinon, 4-CMC Clephedron, 4-MMC Mephedron. Analytisches Referenzmaterial ausschließlich für Labor- und Forschungszwecke; nicht für den menschlichen Verzehr. Geprüfte Identitäts- und physikalisch-chemische Parameter stehen in der Tabelle der Produkteigenschaften.

Geprüftes Pharmakologie- & Toxikologie-Dossier

2-MMC (Orthomephedrone / 2-Methylmethcathinone)

Stimulant (Catecholamine-Preferring SNDRA) Substituted cathinone (ortho-methylated methcathinone)
Geprüfte PubChem- & CAS-Identität C11H15NO · CAS 1246911-71-6 · CID 56603536
Kalibrierte Lieferform Reines Kristall / Analyse-Pulver (≥98 %)
≥98 % analytische Reinheit geprüft 177.25 g/mol
WHO-, PubMed- & PubChem-Quellen 4 · verified sources

Rezeptor-Telemetrie & Wirkmechanismus

DAT Dopamine Transporter 81 nM
NET Norepinephrine Transporter 53 nM
SERT Serotonin Transporter 490 nM

Monoamine releasing agent (SNDRA) whose ortho-methyl ring substituent reduces overall transporter potency—especially at SERT—relative to 3-MMC and 4-MMC. In rat brain synaptosomes (Walther et al., 2018), 2-MMC exhibits NET EC50 = 53 ± 4 nM, DAT EC50 = 81 ± 8 nM, and SERT EC50 = 490 ± 15 nM (SERT/DAT ratio ~6.0 in Walther et al. and 3.5 in Blough et al.). This catecholamine-dominant profile produces brisk wakefulness, focus, and modest mood elevation without MDMA-like social bonding.

Biotransformation & Active Metabolites

Academic reviews note that human pharmacokinetics and controlled clinical studies of 2-MMC have not yet been systematically characterized; EUDA completed risk assessment measures in 2025–2026.

Zeitliche Pharmakokinetik

Clean, functional-to-recreational dopaminergic stimulant delivering alert focus, talkativeness, and moderate mood lift over 3–5 hours orally, followed anecdotally by a milder comedown than 3-MMC or 4-MMC.

  1. Onset 20–45 minutes oral (5–10 minutes mucosal)
  2. Peak Window ~45–90 minutes oral (1–1.5 hours mucosal)
  3. Total Window 3–5 hours oral (2–4.5 hours mucosal)
  4. Residual / Half-Life 1–3 hours of residual wakefulness; comedown is anecdotally reported as milder than 3-MMC/4-MMC; human plasma half-life is unverified.

Roughly ~2.9-fold less potent at DAT than 3-MMC and ~4.2-fold weaker at SERT than 4-MMC. Harm-reduction apps (KnowDrugs) list 50–100 mg oral as common, while Swedish/European user reports span 60 mg up to 150–200 mg; high doses taken to replicate 3-MMC/4-MMC mood elevation instead trigger inward-focused, isolating overstimulation, immediate short-term memory disruption, anxiety, and tachycardia.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
15–20 mg oral (mucosal: 10 mg)
Cognitive & Sensory

Subtle mental wakefulness and mild reduction in fatigue.

Somatic & Autonomic

Slight increase in alertness and resting pulse.

Light
20–60 mg oral (KnowDrugs 20–50 mg; mucosal: 15–40 mg)
Cognitive & Sensory

Clear focus, task motivation, conversational ease, and gentle mood lift.

Somatic & Autonomic

Light energy boost, mild dry mouth, and appetite suppression.

Common Reference
60–120 mg oral (KnowDrugs 50–100 mg; mucosal: 40–80 mg)
Cognitive & Sensory

Solid dopaminergic stimulation, talkativeness, and alertness without heavy serotonergic haze.

Somatic & Autonomic

Elevated heart rate and blood pressure, sweating, mild jaw tension, and cool hands.

Strong
120–180 mg oral (KnowDrugs 100–135 mg, EU user reports up to 150–200 mg; mucosal: 80–100 mg)
Cognitive & Sensory

Intense stimulation that can turn inward-focused or isolating, accompanied by acute short-term memory disruption and restlessness.

Somatic & Autonomic

Pronounced tachycardia, bruxism, vasoconstriction, tremor, and prolonged difficulty sleeping.

Heavy / Toxic Zone
180–200+ mg oral (mucosal: 100+ mg)
Cognitive & Sensory

Acute anxiety, paranoia, hallucinations, confusion, and stimulant psychosis.

Somatic & Autonomic

Severe hypertension, palpitations, chest pain, hyperthermia, and seizure risk.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Inhibiting monoamine oxidase during catecholamine/serotonin release precipitates fatal hypertensive crisis, arrhythmias, and hyperthermia.

Other strong stimulants and vasoconstrictors (Cocaine, alpha-PVP, alpha-PHP, MDPHP, Hexen, NEP, 25x-NBOMe)

Synergistic noradrenergic and dopaminergic strain sharply elevates risk of vasospasm, severe hypertension, and cardiac arrest.

Tramadol

Lowers seizure threshold while adding monoaminergic toxicity.

Hohes Risiko — Vermeiden

MDMA, 4-MMC, or 3-MMC

Compounds heart rate, blood pressure, hyperthermia, and neurotoxic strain.

Alcohol and GHB/GBL

Masks alcohol/GHB sedation, increasing risk of dehydration, cardiac strain, and delayed depressant overdose.

Vorsicht / Abschwächung

Cannabis

Can intensify anxiety, tachycardia, and 2-MMC's tendency toward acute short-term memory disruption.

High-dose Caffeine

Adds peripheral adrenergic jitteriness and palpitations without increasing mood elevation.

Isomeren- & Strukturvergleich

Compared to 3-MMC and 4-MMC, 2-MMC is pharmacologically less potent and far less serotonergic (SERT EC50 490 nM vs. 268 nM and 118 nM), feeling much closer to a plain catecholaminergic stimulant than MDMA—more clear-headed at moderate amounts, less emotionally bonding (and sometimes inward-focused at high amounts), with anecdotally milder comedowns. Compared to 2-CMC, 2-MMC is ~2.2-fold stronger at DAT (81 nM vs. 179 nM).

Stabilität & Lagerung

Form: White to off-white crystalline powder or clear/translucent crystal shards as the monohydrochloride salt (MW 213.70 g/mol). · Freely soluble in water, methanol, and ethanol as the hydrochloride salt.

Store in an airtight, light-protected container in a cool, dry environment.

Cross-Tolerance & Dependence Profile

Cross-tolerant with 3-MMC, 4-MMC, 2-CMC, and amphetamines; tolerance halves in 3–7 days and resets in 1–2 weeks. Induces craving with repeated use, though academic reviews note potentially lower comedown-driven repeated exposure pressure than 3-MMC.

Analytische & toxikologische Monographie

2-MMC (orthomephedrone; 2-(methylamino)-1-(2-methylphenyl)propan-1-one; freebase CAS 1246911-71-6, hydrochloride CAS 1246815-51-9, PubChem CID 56603536) is the ortho-methylated regioisomer of mephedrone and metaphedrone, supplied as pure analytical crystalline powder or crystals (C11H15NO, 177.25 g/mol). Because the ortho-methyl substituent sterically restricts interaction with the serotonin transporter, synaptosomal release studies (Walther et al., 2018) show 2-MMC acts primarily as a norepinephrine and dopamine releasing agent (NET EC50 = 53 nM, DAT EC50 = 81 nM) with substantially weaker serotonin efflux (SERT EC50 = 490 nM; SERT/DAT ratio ~6.0). Consequently, 2-MMC produces brisk alertness, conversational fluency, and moderate dopaminergic mood lift without the deep MDMA-like emotional 'roll' of 4-MMC. No controlled human clinical trials exist for 2-MMC; across harm-reduction databases and European academic reviews, oral threshold effects appear around 15–20 mg, light functional stimulation spans 20–60 mg, common stimulation sits at 60–120 mg (KnowDrugs 50–100 mg), strong intensity with inward-focused overstimulation and acute short-term memory disruption emerges at 120–180 mg, and heavy cardiovascular/psychiatric toxicity risks escalate above 180–200 mg. Oral effects peak around 45 minutes within a 3–5 hour total window, while mucosal administration (common 40–80 mg) begins within 5–10 minutes and lasts 2–4.5 hours. Escalating doses to chase an absent serotonergic 'roll' disproportionately drives tachycardia, hallucinations, and paranoia, whereas moderate single amounts anecdotally leave a milder comedown than 3-MMC or 4-MMC. Compared to 2-CMC, 2-MMC is ~2.2-fold more potent at DAT. Never mix 2-MMC with MAOIs, tramadol, cocaine, pyrovalerones, NEP/Hexen, MDMA, or 25x-NBOMe.

Vergleich in der Gruppe „Cathinon-Derivate“ — ähnliche Verbindungen im Überblick

Direkter Vergleich der chemischen Parameter, Stellungsisomere und verfügbaren Portionsgrößen dieser Stoffklasse:

Verbindung Summenformel Molmasse CAS-Nummer Portionen & Preis ab Blatt
2-MMC 2-Methylmethcathinon Aktuelles Produkt
C11H15NO 177.24 g/mol 1246911-71-6 1 g – 1000 g · 10.00 CHF Aktuelles Produkt
3-MMC 3-Methylmethcathinon Stellungsisomer (C11H15NO)
C11H15NO 177.24 g/mol 1246816-62-5 1 g – 1000 g · 10.00 CHF Zur Karte →
2-CMC Gleiche Stoffklasse (Cathinon-Derivate)
C10H12ClNO 197.66 g/mol 1246911-70-5 1 g – 1000 g · 5.00 CHF Zur Karte →
3-CMC Clofedron Gleiche Stoffklasse (Cathinon-Derivate)
C10H12ClNO 197.66 g/mol 1049677-59-9 1 g – 1000 g · 5.00 CHF Zur Karte →
4-CMC Clephedron Gleiche Stoffklasse (Cathinon-Derivate)
C10H12ClNO 197.66 g/mol 1225843-86-6 1 g – 1000 g · 5.00 CHF Zur Karte →

Diese Angebote haben Sie angesehen

Das könnte Sie auch interessieren